sagimet.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow:
Meta Tags
Title Sagimet Biosciences - Sagimet
Description Posters & Sagimet is pharmaceutical company developing novel therapeutics to treat important diseases .Our lead product candidate TVB-2640 is an oral, highly potent, selective and reversible, first-in-class FASN
Keywords N/A
Server Information
WebSite sagimet faviconsagimet.com
Host IP 52.41.138.247
Location United States
Related Websites
Site Rank
More to Explore
sagimet.com Valuation
US$3,948,173
Last updated: 2023-04-28 12:58:29

sagimet.com has Semrush global rank of 2,680,811. sagimet.com has an estimated worth of US$ 3,948,173, based on its estimated Ads revenue. sagimet.com receives approximately 455,559 unique visitors each day. Its web server is located in United States, with IP address 52.41.138.247. According to SiteAdvisor, sagimet.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,948,173
Daily Ads Revenue US$3,645
Monthly Ads Revenue US$109,334
Yearly Ads Revenue US$1,312,008
Daily Unique Visitors 30,371
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
sagimet.com. A 299 IP: 52.41.138.247
sagimet.com. A 299 IP: 35.167.137.197
sagimet.com. NS 86400 NS Record: ns-546.awsdns-04.net.
sagimet.com. NS 86400 NS Record: ns-94.awsdns-11.com.
sagimet.com. NS 86400 NS Record: ns-1419.awsdns-49.org.
sagimet.com. NS 86400 NS Record: ns-2014.awsdns-59.co.uk.
sagimet.com. MX 3600 MX Record: 0 sagimet-com.mail.protection.outlook.com.
sagimet.com. TXT 1800 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-04-28 12:58:29
table td { font-size: 16px !important; } Hit enter to search or ESC to close About Overview Senior Management Board of Directors Scientific advisors Careers Science FASN Posters/Publications News Press Releases Programs Overview Pipeline Contact A clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers. Our expertise in FASN enables us to break new ground in targeting dysfunctional metabolic pathways. We’ve created a platform of proprietary, selective FASN inhibitors. Our lead product candidate TVB-2640 is an oral, highly potent, selective and reversible, first-in-class FASN inhibitor. TVB-2640 is rapidly absorbed in the human body with well-behaved pharmacokinetics. Pipeline FASN Inhibitor Indication Preclinical Phase 1 Phase 2 Phase 3 TVB-2640 NASH Title 58 % TVB-2640 Oncology Title 58 % TVB-3567 Undisclosed Title 22 % FASN Inhibitor – TVB-2640 Indication – NASH Phase 2 Title 70
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 21 Oct 2021 13:30:25 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Set-Cookie: AWSALB=Xyf1/pCSQCDE7SIDJ1M79AHdw+hsZIYV6F53TFHZ3qAZESdG8ZIgXw58lDthpzgTT6syPhygc8DUdcNlJs50B9kpyAk1IaDCThvLuyLad1CLa15feNtogU49VqmJ; Expires=Thu, 28 Oct 2021 13:30:25 GMT; Path=/
Set-Cookie: AWSALBCORS=Xyf1/pCSQCDE7SIDJ1M79AHdw+hsZIYV6F53TFHZ3qAZESdG8ZIgXw58lDthpzgTT6syPhygc8DUdcNlJs50B9kpyAk1IaDCThvLuyLad1CLa15feNtogU49VqmJ; Expires=Thu, 28 Oct 2021 13:30:25 GMT; Path=/; SameSite=None
Server: Apache
X-Powered-By: PHP/7.2.13
X-Redirect-By: WordPress
X-Frame-Options: SAMEORIGIN
Location: https://sagimet.com/

HTTP/2 200 
date: Thu, 21 Oct 2021 13:30:26 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALB=8E88jzfsun3k/3jjj3tKZZ4dWg+Aoy8BOkK3kZA/swN7aiB//iVXCnmUDPAWmU+xIhsG4r3VJZxj3A+M6lscpbHMGyqL6I9tW9QcuptjgxAgcMGoMvM05i5Cui6R; Expires=Thu, 28 Oct 2021 13:30:25 GMT; Path=/
set-cookie: AWSALBCORS=8E88jzfsun3k/3jjj3tKZZ4dWg+Aoy8BOkK3kZA/swN7aiB//iVXCnmUDPAWmU+xIhsG4r3VJZxj3A+M6lscpbHMGyqL6I9tW9QcuptjgxAgcMGoMvM05i5Cui6R; Expires=Thu, 28 Oct 2021 13:30:25 GMT; Path=/; SameSite=None; Secure
server: Apache
x-powered-by: PHP/7.2.13
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-frame-options: SAMEORIGIN
cache-control: max-age=0, no-cache
sagimet.com Whois Information
Domain Name: SAGIMET.COM
Registry Domain ID: 2374333637_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.registrar.amazon.com
Registrar URL: http://registrar.amazon.com
Updated Date: 2021-02-22T23:48:32Z
Creation Date: 2019-03-28T22:21:59Z
Registry Expiry Date: 2022-03-28T22:21:59Z
Registrar: Amazon Registrar, Inc.
Registrar IANA ID: 468
Registrar Abuse Contact Email: abuse@amazonaws.com
Registrar Abuse Contact Phone: +1.2067406200
Domain Status: ok https://icann.org/epp#ok
Name Server: NS-1419.AWSDNS-49.ORG
Name Server: NS-2014.AWSDNS-59.CO.UK
Name Server: NS-546.AWSDNS-04.NET
Name Server: NS-94.AWSDNS-11.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T07:20:27Z <<<

Copyright © 2022 WebZZ.US 0.0218